1090627

Aurobindo Pharma Ltd — FEI 3004021229

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
121521 CFR 211.67(b)Written procedures not established/followed
126321 CFR 211.68(b)Computer control of master formula records
176821 CFR 211.137(b)Storage conditions
203121 CFR 211.194(a)Complete test data included in records
362321 CFR 211.170(a)Active ingredient retained sample kept
430521 CFR 211.68(b)Backup data not assured as exact and complete
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up
440221 CFR 211.192Written record of investigation incomplete